Vaxcyte SVP Finance, CAO Elvia Cowan disposes of 19,000 common shares for $1,647,060

PUBT · 2d ago
Vaxcyte SVP Finance, CAO Elvia Cowan disposes of 19,000 common shares for $1,647,060
  • Vaxcyte SVP, Finance and chief accounting officer Elvia Cowan exercised stock options for 19,000 shares on Oct. 5.
  • She sold 19,000 shares the same day at USD 86.74.
  • Holdings fell to 27,860 shares following the sale.
  • Options beneficially owned rose to 74,068, with the exercised grant priced at USD 25.92.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001960048-26-000013), on October 07, 2026, and is solely responsible for the information contained therein.